Serum α-chlorofatty acid as a biomarker for baseline subclinical cardiovascular disease in systemic lupus erythematosus
MA Mahieu(Northwestern University), Rosalind Ramsey‐Goldman(Northwestern University), Camelia P. Guild(Northwestern University), Daniel Edmundowicz(Temple University Hospital), George T. Kondos(University of Illinois Chicago), DA Ford(Saint Louis University), CJ Albert(Saint Louis University), James Carr(Northwestern University)
Cited by 0
Related Papers
Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
|Gastroenterology|2010|649
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
|Nature Genetics|2011|284
Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|274
Treatment of Patients Admitted to the Hospital With Congestive Heart Failure: Specialty-Related Disparities in Practice Patterns and Outcomes
|Journal of the American College of Cardiology|1997|251
Increased Risk of Fracture in Patients Receiving Solid Organ Transplants
|Journal of Bone and Mineral Research|1999|251